Evidence map›Paper›PMID 31561422›Full record

ArticleMedicina (Kaunas, Lithuania)2019

Savić Borivoje, Stanojlović Svetlana, Hadži-Milić Milan, Đonović Nela, Milošević-Đorđević Olivera, Milisavljević Filip, Stojković Milenko, Pajić Srbislav

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Savić BorivojeClinic for Eye Diseases, Clinical Center of Serbia, 11000 Belgrade, Serbia. sb.bora@gmail.com.
Stanojlović SvetlanaClinic for Eye Diseases, Clinical Center of Serbia, 11000 Belgrade, Serbia. stanojlovic.svetlana@gmail.com.
Hadži-Milić MilanDepartment of Surgery, Orthopedics and Ophthalmology, Faculty of Veterinary Medicine, 11000 Belgrade, Serbia. milanhmilic@gmail.com.
Đonović NelaDepartment of Hygiene and Ecology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia. nela@medf.kg.ac.rs.
Milošević-Đorđević OliveraDepartment of Genetics, Faculty of Medical Science, University of Kragujevac, 34000 Kragujevac, Serbia. olivera@kg.ac.rs.
Milisavljević FilipClinic of Neurosurgery, Clinical Center of Serbia, 11000 Belgrade, Serbia. milisavljevic93@gmail.com.
Stojković MilenkoClinic for Eye Diseases, Clinical Center of Serbia, 11000 Belgrade, Serbia. milenko.stojkovic@mfub.bg.ac.rs.
Pajić SrbislavEmergency Center, Clinic for Emergency surgery, Clinical Center of Serbia, 11000 Belgrade, Serbia. nevus-ng@hotmail.com.ORCID 0000-0002-4381-8270
Centar za Promociju Nauke · RSUniversity of Belgrade · RSUniversity of Kragujevac · RSCenter for Health, Exercise and Sport Sciences · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic VariationAdultFemaleFluorescent Antibody Technique, IndirectHerpesvirus 1, HumanHumansImmunity, InnateInterferon LambdaInterferonsInterleukinsKeratitis, HerpeticMaleMiddle AgedRecurrenceInterferon Lambdainterferon-lambda, humanInterferonsInterleukinsherpes simplex virus type 1 (HSV-1)keratitistype III interferons (IL28B) genotype

Identifiers

PMID31561422
PMCPMC6843532
OpenAlexW2976078977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.